After a preview of TraceLink’s second annual Global Drug Supply, Safety and Traceability survey has revealed disparity in terms of readiness for the FMD between pharma companies and CMOs, three experts give us their perspectives on serialisation
Here, Scott Allison, president, Life Sciences & Healthcare, DHL, and Keith Turner, CIO Chief Development Office, Life Sciences & Healthcare, Service Logistics, DHL Supply Chain, look at the importance of blockchain in logistics.
Here, Mark Tempest, VWV partner in the Insolvency and Restructuring and Pharmaceuticals and Life Sciences teams, looks at the construction giant’s case in more detail and what pharma and life sciences should consider in order to protect themselves.
As more pharma manufacturers outsource elements of their process, Steve Cottrell, president at Maetrics, looks at the importance of supply chain visibility and how companies can regain full control.
Adrián Abad Fustero, Supply Chain Director of Medis, will be presenting at FutureLink Munich on the ‘The Virtual Broker: Negotiating Win-Wins with Track & Trace Partners’. In a preview of his presentation, we interviewed Fustero on the role of broker
In this online exclusive, Alex Aves, marketing executive, Rephine, looks at blockchain in more detail including how it may benefit the pharmaceutical sector.
We speak with the CEO of Controlant, Gisli Herjolfsson, about the company and its cold chain solutions that are revolutionising delivery of vaccines to developing countries and more.
Scott Allison, president, Life Sciences & Healthcare Sector, DHL, gives us a rundown of the connected warehouse and how innovations in logistics are benefitting this rapidly changing world.
The industry’s largest survey on serialisation readiness, including data from 660 respondents in the pharma supply chain, has been published by TraceLink.
The ‘Amazon Effect’, new address systems and Brexit are driving change, in this online opinion article, BluJay Solutions presents the three most important trends to prepare for in 2018.
Nearly all supply chain and operations professionals are not fully capitalising on digitalisation technologies, according to new research from logistics company, DHL.
All signs are that the life sciences and healthcare market is ripe for disruption, with ecommerce coming into its own in the sector. Scott Allison, president Life Sciences & Healthcare, DHL, lists five reasons as to why it is happening now.
